Ortin Global Ltd (ORTINGLOBE) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 539287 | NSE: ORTINGLOBE | Pharmaceuticals & Drugs | Small Cap

Ortin Global Share Price

15.38 1.39 9.94%
as on 05-Dec'25 11:34

Ortin Global Ltd (ORTINGLOBE) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 539287 | NSE: ORTINGLOBE | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Ortin Global

Based on:

M-Cap below 100cr DeciZen not available

Ortin Global stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
11.4 Cr.
52-wk low:
9.6
52-wk high:
22.9

Is Ortin Global Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Ortin Global: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Ortin Global Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 11%9.6%10.1%11.8%8.9%3.3%1.6%1.7%-60.1%-24.4%-
Value Creation
Index
-0.2-0.3-0.3-0.2-0.4-0.8-0.9-0.9-5.3-2.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 62.966.879.71681978.28.262.10.30
Sales YoY Gr.-6.1%19.4%110.5%17.7%-95.9%0.7%-26.9%-65%-83.9%-
Adj EPS 0.50.20.30.8-0.31.2-0.5-0.1-8-1.1-1.2
YoY Gr.--50%37.5%127.3%-142.7%NA-142.2%NANANA-
BVPS (₹) 13.713.814.214.814.11413.513.43.52.41.6
Adj Net
Profit
0.80.40.61.3-0.61-0.4-0.1-6.5-0.9-1
Cash Flow from Ops. 0.51.91.66.53.3182.2-0.3-4.8-0.4-
Debt/CF from Ops. 40.48.911.135.90.42.9-25.5-0.4-0.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -44%-72%-65.4%-83.9%
Adj EPS -209.2%NANANA
BVPS-17.5%-29.6%-43.5%-30%
Share Price -9.1% -10.5% -12.7% -19.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
3.51.82.45.2-2.25.4-3.6-0.7-95.5-35.8-58.1
Op. Profit
Mgn %
9.486.93.72.915.34.68.7-207.8-258.2-651
Net Profit
Mgn %
1.30.60.70.8-0.311.6-4.8-1.4-309.5-251.3-731.7
Debt to
Equity
0.90.70.70.80.80.60.60.60.60.10.7
Working Cap
Days
2352232051441592,1752613641,0294,6367,024
Cash Conv.
Cycle
11712711861512631822566011,0733,683

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Ortin Global Ltd.

Standalone Consolidated
TTM EPS (₹) -1.2 -
TTM Sales (₹ Cr.) 0.1 -
BVPS (₹.) 1.6 -
Reserves (₹ Cr.) -7 -
P/BV 8.74 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 9.57 / 22.88
All Time Low / High (₹) 6.60 / 52.25
Market Cap (₹ Cr.) 11.4
Equity (₹ Cr.) 8.1
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Ortin Global:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Ortin Global - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Ortin Global

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales62.9466.7579.71167.76197.398.178.236.022.110.34
Operating Expenses 57.0561.4074.31161.52191.716.927.865.508.651.23
Manufacturing Costs10.239.449.5418.2126.570.510.520.390.590.09
Material Costs41.3345.5957.59134.82154.623.954.653.393.720.21
Employee Cost 2.132.592.783.684.720.850.740.680.490.09
Other Costs 3.373.784.394.825.801.611.951.043.860.84
Operating Profit 5.895.355.406.245.681.250.380.52-6.54-0.88
Operating Profit Margin (%) 9.4%8.0%6.8%3.7%2.9%15.2%4.6%8.6%-309.0%-258.0%
Other Income 0.570.420.450.570.200.050.190.040.170.04
Interest 3.422.943.493.223.210.870.810.400.480
Depreciation 1.651.701.691.751.960.290.290.250.230.01
Exceptional Items 0000000-0.03-00.02
Profit Before Tax 1.401.130.681.840.720.14-0.53-0.11-7.08-0.84
Tax 0.560.6300.561.28-0.81-0.13-0.020.970.01
Profit After Tax 0.830.500.681.28-0.560.95-0.40-0.09-8.04-0.85
PAT Margin (%) 1.3%0.8%0.9%0.8%-0.3%11.6%-4.8%-1.6%-380.0%-247.0%
Adjusted EPS (₹)0.50.30.40.8-0.31.2-0.5-0.1-9.9-1.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 23.2723.4024.0825.0923.8211.3610.9610.862.821.98
Share Capital 16.9416.9416.9416.9416.948.138.138.138.138.13
Reserves 6.336.467.148.156.883.222.832.73-5.31-6.15
Minority Interest0000000000
Debt20.0216.5416.1419.4719.576.946.146.451.800.25
Long Term Debt4.801.421.484.744.901.441.732.961.800.25
Short Term Debt15.2215.1214.6614.7414.675.504.423.4800
Trade Payables2.817.0516.5847.60601.340.791.550.080.04
Others Liabilities 19.7114.5416.8612.9213.131.632.822.3431.45
Total Liabilities 65.8261.5373.66105.09116.5221.2720.7021.207.713.72

Fixed Assets

Gross Block32.9322.3523.3126.3229.4418.9119.0418.780.210.21
Accumulated Depreciation11.301.673.285.036.994.544.834.820.200.21
Net Fixed Assets 21.6320.6920.0321.2922.4514.3814.2113.960.010
CWIP 00.350.400.530.430.430.430.4300
Investments 0.030.070.080.080.0700000
Inventories16.8417.6524.0236.9649.901.831.742.600.050.02
Trade Receivables9.1315.2421.8537.8337.153.913.243.421.770.26
Cash Equivalents 1.661.431.692.142.500.180.600.262.340.37
Others Assets 16.536.105.596.254.020.540.490.543.543.06
Total Assets 65.8261.5373.66105.09116.5221.2720.7021.207.713.72

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.521.941.566.523.3018.032.15-0.25-4.79-0.41
PBT 1.401.130.681.840.720.14-0.53-0.11-7.08-0.84
Adjustment 4.491.691.395.215.411.161.100.642.860.01
Changes in Working Capital -1.46-0.260.06-0.1-1.9916.741.58-0.780.720.41
Tax Paid -0.50-0.62-0.58-0.42-0.83000-1.290
Cash Flow From Investing Activity -0.86-1.26-0.90-3.27-3.090.07-0.130.0112-0
Capex -1.44-0.76-0.74-3.01-3.120-0.130.0112-0
Net Investments 0-0.01-0.01-0.01-0.080.070000
Others 0.57-0.49-0.15-0.250.1000000
Cash Flow From Financing Activity 0.27-0.820.07-2.89-1.33-9.86-0.470.90-3.490.33
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0.27-0.820.070.333.09-3.4600-1.16-1.55
Interest Paid 000-3.22-3.21-0.87-0.81-0.40-0.48-0
Dividend Paid 0000000000
Others 0000-1.21-5.520.341.30-1.851.88
Net Cash Flow -0.07-0.140.730.37-1.128.251.550.663.72-0.09

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.652.162.865.21-2.315.38-3.57-0.86-117.48-35.26
ROCE (%)11.019.5810.1411.768.933.271.561.66-60.11-24.36
Asset Turnover Ratio1.011.051.191.881.780.120.390.290.150.06
PAT to CFO Conversion(x)0.633.882.295.09N/A18.98N/AN/AN/AN/A
Working Capital Days
Receivable Days71678465699181592024481,081
Inventory Days105949466801,1567913222937
Payable Days873975871272,8348312680102

Ortin Global Ltd Stock News

Ortin Global Ltd FAQs

The current trading price of Ortin Global on 05-Dec-2025 11:34 is ₹15.38.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Ortin Global stood at ₹11.38.
The latest P/E ratio of Ortin Global as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Ortin Global as of 04-Dec-2025 is 8.74.
The 52-week high of Ortin Global is ₹22.88 and the 52-week low is ₹9.57.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ortin Global is ₹0.13 ( Cr.) .

About Ortin Global Ltd

Ortin Laboratories established in the year 1986  was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Quality is the hallmark of Ortin. At every stage of production from raw material to finished products, highest standard of quality is ensured with the help of most modern equipment and experienced personnel.This unflinching perseverance towards quality has helped the company to earn enormous goodwill & trust, both from medical profession and pharmaceutical trade.

Being in partnership with the world means respecting its resources without compromise and so at Ortin, continuous process evaluation and monitoring waste recoveries ensure that the focus is maintained. Specialized facilities have helped us to earn a reputation for the expert handling of hazardous materials in the form of reactants and products. Teams from the ministry of health regularly inspect the company's plant. Every care is taken for treatment of solid wasters, discharged liquids and atmospheric releases.

Ortin is contemplating an entry into the OTC segment as part of its long term growth strategy. It is channeling its efforts towards building an overseas marketing network in order to enhance exports to third world countries. Ortin proposes to be certified as a WHO GMP Unit and to launch innovative Biotechnology products in Orthopedic and Dental Segments. The success behind them is only the Reliance which they carry for their Quality from the people all over the country. Their motto, right from their inception has been towards Quality and they still maintain them and continue to do so in future.

Products manufactured by the company include:

  • Capsules
  • Syrups / Dry syrups
  • Powders
  • Second Division Products
  • Generic Products

Achievements/ recognition :

  • Ortin has been certified as an ISO 9001: 2000 company by the internationally recognized Quality Management Certification Body, the National Quality Assurance, UK in pursuance of its focus towards Quality with its Policy to enhance customer satisfaction by providing Quality Pharmaceutical Formulations at optimum cost and maintain profitability through continual improvement of Quality Management Sytems and cGMP.
  • Ortin is honored as a registered Supplier of Drugs & Medicines with the most reputed Central, State & Quasi-Government Organizations & Institutions of our Country such as the Railways, Health Ministry, Defence, Posts & Telegraph, Electricity Hospitals, Transport Organizations, Research Institutions such as JIPMER, IICT etc.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×